05/20/2026

Product Updates

Regeneron's Lynozfic J-Code Availability

Merck's Keytruda Qlex Receives Permanent HCPCS J-Code

New Indication for Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with platinum-resistant epithelial ovarian cancer

More Info